David C. Drahms

OUP Management Co. LLC (Osage Partners) is a venture capital firm founded in 1990 by Robert Adelson and Louis Berneman. The firm is headquartered in Bala Cynwyd, Pennsylvania.

Circonus, Inc. engages in the provision of real-time monitoring and analytics platform. It offers Circonus platform, a machine data intelligence technology capable of handling unprecedented data volume in real time to drive critical business insight and value. Its solutions include infrastructure monitoring, Internet of Things and IIoT, time series database, cloud monitoring, container monitoring, DevOps monitoring, Adtech, Fintech, logistics and telematics, smartgrid/utilities, and entertainment and streaming media. The company was founded in 2010 by Theo Schlossnagle and is headquartered in Fulton, MD.

Indico Data Solutions, Inc. engages in the development of intelligent process automation solutions. Its products include Indico Discover, Indico Review, Indico Teach, and Indico Enterprise AI APIs. The company was founded by Slater Victoroff, May Madison, Diana Yuan, and Alec Radford in 2014 and is headquartered in Boston, MA.

Full Measure Education, Inc. provides education technologies. It is a student lifecycle and retention management company developing next generation student facing mobile/social/web technology and human powered retention services that keep students from dropping out of college. The company was founded by Robert Abraham, Charles Brodsky, Anthony Banford and Gregory Davies in 2013 and is headquartered in Washington, DC.

VividCortex, Inc. engages in the development of cloud-hosted platform to improve firm's database performance, efficiency, and uptime. It offers VividCortex, a software-as-a-service platform which features Explorer, Profiler, Notebooks, Summary, Queries, Faults, Events, Charts, and Metrics. The company was founded by Kyle John Redinger and Baron Schwartz in 2012 and is headquartered in Charlottesville, VA.

Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA.